Hilden J M, Frestedt J L, Moore R O, Heerema N A, Arthur D C, Reaman G H, Kersey J H
University of Minnesota, Children's National Medical Center, Minneapolis 55455, USA.
Blood. 1995 Nov 15;86(10):3876-82.
Molecular techniques to detect MLL (11q23) and AF-4 (4q21) gene rearrangements are being evaluated for use in stratification of patients into prognostic groups. We studied 15 cases of infant acute lymphoblastic leukemia (ALL) with Southern blotting for MLL gene rearrangement and reverse transcriptase-polymerase chain reaction (RT-PCR) for t(4;11) fusion transcripts and compared the results to cytogenetic and clinical data. Our results indicate that classic t(4;11)(q21;q23) translocations are detected by RT-PCR; however, unusual 4;11 translocations still require additional investigation. We also extended and updated our original study of MLL gene rearrangement in infant ALL to 40 patients with longer follow-up and show that the group with germline configuration of the MLL gene continues to have an excellent outcome. The results of salvage therapy (bone marrow transplantation or chemotherapy) suggest that transplant may show advantage. Preliminary results of the use of RT-PCR to assess minimal disease are also reported.
用于检测MLL(11q23)和AF-4(4q21)基因重排的分子技术正在被评估用于将患者分层到预后组。我们用Southern印迹法研究了15例婴儿急性淋巴细胞白血病(ALL)的MLL基因重排,并通过逆转录聚合酶链反应(RT-PCR)检测t(4;11)融合转录本,同时将结果与细胞遗传学和临床数据进行比较。我们的结果表明,经典的t(4;11)(q21;q23)易位可通过RT-PCR检测到;然而,不寻常的4;11易位仍需要进一步研究。我们还将最初对婴儿ALL中MLL基因重排的研究扩展并更新至40例患者,随访时间更长,结果显示MLL基因呈种系构型的组预后仍然良好。挽救治疗(骨髓移植或化疗)的结果表明移植可能具有优势。还报告了使用RT-PCR评估微小疾病的初步结果。